We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
1626
Ollie's Bargain Outlet
OLLI
$4.8B
$2.61M ﹤0.01%
29,924
-1,149
-4% -$108K
AVLR
1627
DELISTED
Avalara, Inc.
AVLR
$2.6M ﹤0.01%
36,015
+29,114
+422% +$1.88M
OGS icon
1628
ONE Gas
OGS
$4.96B
$2.6M ﹤0.01%
28,785
+896
+3% +$79.3K
BWXT icon
1629
BWX Technologies
BWXT
$15.5B
$2.58M ﹤0.01%
49,553
+1,453
+3% +$72.6K
TCF
1630
DELISTED
TCF Financial Corporation Common Stock
TCF
$2.58M ﹤0.01%
62,774
+7,560
+14% +$314K
VG
1631
DELISTED
Vonage Holdings Corporation
VG
$2.58M ﹤0.01%
227,526
+158,949
+232% +$1.72M
VONV icon
1632
Vanguard Russell 1000 Value ETF
VONV
$22B
$2.57M ﹤0.01%
46,098
+2,146
+5% +$118K
EWT icon
1633
iShares MSCI Taiwan ETF
EWT
$11B
$2.57M ﹤0.01%
73,488
-1,468
-2% -$50.7K
HIE
1634
DELISTED
Miller/Howard High Income Equity Fund
HIE
$2.56M ﹤0.01%
230,380
-396
-0.2% -$4.51K
PBH icon
1635
Prestige Consumer Healthcare
PBH
$2.51B
$2.55M ﹤0.01%
80,390
-5,966
-7% -$177K
EQC
1636
DELISTED
Equity Commonwealth
EQC
$2.54M ﹤0.01%
78,256
+26,207
+50% +$851K
CISN
1637
DELISTED
Cision Ltd. Ordinary Share
CISN
$2.54M ﹤0.01%
216,165
-29,050
-12% -$344K
BCO icon
1638
Brink's
BCO
$4.55B
$2.53M ﹤0.01%
31,199
+3,097
+11% +$247K
LOPE icon
1639
Grand Canyon Education
LOPE
$3.82B
$2.53M ﹤0.01%
21,635
+12,005
+125% +$1.43M
GBAB
1640
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$389M
$2.53M ﹤0.01%
105,449
+2,853
+3% +$66.3K
JBGS
1641
JBG SMITH
JBGS
$653M
$2.53M ﹤0.01%
64,219
+3,750
+6% +$154K
RSPF icon
1642
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$309M
$2.52M ﹤0.01%
58,165
+9,222
+19% +$392K
OLN icon
1643
Olin
OLN
$2.15B
$2.51M ﹤0.01%
114,744
+18,104
+19% +$403K
AMWD
1644
DELISTED
American Woodmark
AMWD
$2.51M ﹤0.01%
29,697
+6,873
+30% +$579K
HUBS icon
1645
HubSpot
HUBS
$10.8B
$2.51M ﹤0.01%
14,711
-2,273
-13% -$397K
IR icon
1646
Ingersoll Rand
IR
$33.6B
$2.51M ﹤0.01%
72,522
-13,678
-16% -$442K
BBRE icon
1647
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.25B
$2.5M ﹤0.01%
29,783
+392
+1% +$33K
CRSP icon
1648
CRISPR Therapeutics
CRSP
$5.17B
$2.5M ﹤0.01%
53,030
+1,433
+3% +$57.3K
HNGR
1649
DELISTED
Hanger Inc.
HNGR
$2.5M ﹤0.01%
130,280
+6,016
+5% +$116K
IDU icon
1650
iShares US Utilities ETF
IDU
$1.35B
$2.49M ﹤0.01%
33,044
+2,488
+8% +$185K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.